ACAD Company Profile and Key Details

Q: Who are the executives of ACAD?

Dr. Srdjan R. Stankovic M.D., M.S.P.H.PresMr. Austin D. KimExecutive Vice President, Gen. Counsel & Sec.Mr. James K. KiharaVice President, Chief Accounting Officer & Corporation ControllerMr. Bob MischlerSenior Vice President of Strategy & Technology OperationsMr. Mark C. JohnsonVice President of Investor RelationsMs. Julie FisherSenior Vice President of Marketing & Commercial StrategyMr. Mark C. SchneyerExecutive Vice President & Chief Financial OfficerDr. Mary Ellen TurnerSenior Vice President of Pharmacovigilance & Corporation Safety OfficerMr. Rob AcklesSenior Vice President & Chief People OfficerMs. Holly ValdiviezSenior Vice President & Head of SalesMs. Ponni Subbiah M.D., M.P.H.SVice President, Global Head of Medical Affairs & Chief Medical OfficerMr. Brendan P. TeehanExecutive Vice President, Chief Operating Officer & Head of CommercialMr. Stephen R. Davis J.D.Pres, Chief Executive Officer & Director

NASDAQ : ACAD

ACADIA Pharmaceuticals

$21.24

-0.52-2.39%

Open: 2:11 PM

62.35

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

ACADIA Pharmaceuticals Inc. (ACAD) stock declined over -2.39%, trading at $21.24 on NASDAQ, down from the previous close of $21.76. The stock opened at $21.86, fluctuating between $21.22 and $22.07 in the recent session.

Stock Snapshot

21.76

Prev. Close

3.62B

Market Cap

21.22

Day Low

9.23

P/E Ratio

2.3

EPS (TTM)

-0.14

Cash Flow per Share

21.86

Open

170.49M

Number of Shares

22.07

Day High

99.21%

Free Float in %

2.62

Book Value

773.45K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 14, 2026	21.46	22.13	21.46	22.02	1.97M
Apr 13, 2026	21.53	21.66	20.96	21.46	2.04M
Apr 10, 2026	22.52	22.60	21.42	21.74	849.31K
Apr 09, 2026	22.35	22.67	22.09	22.57	1.23M
Apr 08, 2026	22.85	22.86	22.39	22.56	1.64M
Apr 07, 2026	22.20	22.31	21.90	22.09	1.43M
Apr 06, 2026	21.99	22.74	21.99	22.32	1.28M
Apr 02, 2026	21.85	22.49	21.72	22.20	1.7M
Apr 01, 2026	22.22	22.89	21.99	22.32	1.61M
Mar 31, 2026	21.26	22.39	21.26	22.26	2.21M
Mar 30, 2026	21.16	21.16	20.67	21.07	1.72M
Mar 27, 2026	21.25	21.42	20.75	20.75	1.21M
Mar 25, 2026	21.40	22.37	21.40	22.01	2.31M
Mar 24, 2026	20.82	21.07	20.36	20.96	1.9M
Mar 23, 2026	21.32	21.51	20.94	20.99	1.32M
Mar 20, 2026	20.69	21.06	20.59	20.74	3.25M
Mar 19, 2026	20.09	20.90	19.89	20.72	2.41M
Mar 18, 2026	20.80	20.80	20.13	20.32	2.47M
Mar 17, 2026	21.39	21.62	20.81	20.90	2.42M
Mar 16, 2026	21.04	21.54	20.94	21.39	3.05M

Contact Details

San Diego, CA 92130

United States

https://www.acadia-pharm.com 858 558 2871

About Company

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; Trofinetide, a novel synthetic analog, under phase 3 development for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic, under phase 2 development for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor, under phase 1 development for treating schizophrenia and cognition in Alzheimer's. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.

Stock Peers

ARGX

19.08+2.36%

argenx SE$828.35 REGN

9.05+1.21%

Regeneron Pharmaceuticals, Inc.$755.51 UTHR

0.91+0.16%

United Therapeutics Corporation$578.54 MDGL

-0.68-0.13%

Madrigal Pharmaceuticals, Inc.$524.99 VRTX

4.23+0.96%

Vertex Pharmaceuticals Incorporated$444.28 PRAX

26.6+8.39%

Praxis Precision Medicines, Inc.$343.60 ALNY

6.41+1.92%

Alnylam Pharmaceuticals, Inc.$339.41 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

2.59+0.97%

Krystal Biotech, Inc.$270.00 ASND

1.29+0.52%

Ascendis Pharma A/S$249.84

Frequently Asked Questions

What is the current ACADIA Pharmaceuticals Inc. (ACAD) stock price?

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stock price is $21.24 in the last trading session. During the trading session, ACAD stock reached the peak price of $22.07 while $21.22 was the lowest point it dropped to. The percentage change in ACAD stock occurred in the recent session was -2.39% while the dollar amount for the price change in ACAD stock was - $0.52.

ACAD's industry and sector of operation?

The NASDAQ listed ACAD is part of Biotechnology industry that operates in the broader Healthcare sector. ACADIA Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ACAD?

Dr. Srdjan R. Stankovic M.D., M.S.P.H.
Pres
Mr. Austin D. Kim
Executive Vice President, Gen. Counsel & Sec.
Mr. James K. Kihara
Vice President, Chief Accounting Officer & Corporation Controller
Mr. Bob Mischler
Senior Vice President of Strategy & Technology Operations
Mr. Mark C. Johnson
Vice President of Investor Relations
Ms. Julie Fisher
Senior Vice President of Marketing & Commercial Strategy
Mr. Mark C. Schneyer
Executive Vice President & Chief Financial Officer
Dr. Mary Ellen Turner
Senior Vice President of Pharmacovigilance & Corporation Safety Officer
Mr. Rob Ackles
Senior Vice President & Chief People Officer
Ms. Holly Valdiviez
Senior Vice President & Head of Sales
Ms. Ponni Subbiah M.D., M.P.H.
SVice President, Global Head of Medical Affairs & Chief Medical Officer
Mr. Brendan P. Teehan
Executive Vice President, Chief Operating Officer & Head of Commercial
Mr. Stephen R. Davis J.D.
Pres, Chief Executive Officer & Director

How ACAD did perform over past 52-week?

ACAD's closing price is 56.39% higher than its 52-week low of $14.08 where as its distance from 52-week high of $28.35 is -22.33%.

How many employees does ACAD have?

Number of ACAD employees currently stands at 653.

Link for ACAD official website?

Official Website of ACAD is: https://www.acadia-pharm.com

How do I contact ACAD?

ACAD could be contacted at phone 858 558 2871 and can also be accessed through its website. ACAD operates from 12830 El Camino Real, San Diego, CA 92130, United States.

How many shares of ACAD are traded daily?

ACAD stock volume for the day was 773.45K shares. The average number of ACAD shares traded daily for last 3 months was 1.73M.

What is the market cap of ACAD currently?

The market value of ACAD currently stands at $3.62B with its latest stock price at $21.24 and 170.49M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	653
Beta	0.83
Sales or Revenue	$726.44M
5Y Sales Change%	1.508%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	653
Beta	0.83
Sales or Revenue	$726.44M
5Y Sales Change%	1.508%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

ACAD Company Profile and Key Details

ACADIA Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Dividend & Fair Value

Earnings & Analyst Outlook

Valuation Metrics

Price Forecast & Outlook

Key Takeaways